Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4101–4150 of 18629
Amir Ben-Yohanan, the Chief Executive Officer of the Company shall serve as interim Chief Financial Officer and assume the duties of the principal financial officer of the Company until the Company replaces Mr. Hoey.
the Company appointed Major General (Ret) Alberto “Al” Rosende, age 61, as the Company’s Chief Executive Officer, effective as of the same date.
On August 30, 2024, M2i Global, Inc. (“the Company”) accepted Lieutenant General (Ret) Jeffrey W. Talley’s resignation as President and Chief Executive Officer of the Company.
appointed Richard Christopher, age 54, to the position of Chief Executive Officer
Effective August 28, 2024, Andrew Childs was appointed as Chief Financial Officer (“CFO”) of Pineapple Energy Inc., (the “Company”).
On August 28, 2024, James E. Moylan, Jr., (age 73), Senior Vice President and Chief Financial Officer, notified Ciena of his decision to retire in twelve months, effective August 28, 2025
the Board has appointed Franco Fogliato as Chief Executive Officer (“CEO”) and as a member of the Board, each effective as of September 18, 2024.
On September 4, 2024, after a robust internal and external search, the Board of Directors (the “Board”) of the Company appointed Mr. Konieczny as the Chief Executive Officer of the Company, effective immediately.
On August 28, 2024, the Company entered into a Mutual Separation Agreement (the “Separation Agreement”) with Brendon B. Falconer, the Company’s former Senior Executive Vice President and Chief Financial Officer, pursuant to which the Company and Mr. Falconer mutually agreed that Mr. Falconer’s employment with the Company would terminate effective August 31, 2024.
The Board of Directors of Old National Bancorp (the “Company”) appointed John V. Moran, IV to serve as the Company’s Senior Executive Vice President and Chief Financial Officer, effective August 31, 2024, succeeding Brendon B. Falconer.
On September 1, 2024, the board of directors of the Company (the “Board”) appointed Phillip Eyler as Interim Chief Financial Officer of the Company, effective as of September 1, 2024.
Matteo Anversa, Executive Vice President of Finance, Chief Financial Officer and Treasurer of Gentherm Incorporated (the “Company”), and serving as the Company’s principal financial officer, notified the Company on August 5, 2024 of his decision to resign from such position effective September 1, 2024 to pursue another opportunity.
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
In addition, on August 30, 2024, Charles E. McLaughlin notified the Company of his decision to retire as Senior Vice President and Chief Financial Officer of the Company by the end of the first quarter of 2025.
Michael Katz, age 48, will assume the role of Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2025.
On September 4, 2024, Voya Financial, Inc. (the “Company”) announced that Don Templin, Executive Vice President and Chief Financial Officer, informed the Company of his decision to retire from the Company.
succeed the Company’s current President and Chief Executive Officer, Dr. Stephen Schwartz, who as previously announced is retiring effective as of the Start Date
Effective August 30, 2024, the Board of Directors of Strategic Realty Trust, Inc. (the “Company”) appointed Domenic Lanni 54, to serve as Chief Executive Officer of the Company.
Glynis Bryan, the Company’s Chief Financial Officer, intends to retire as Chief Financial Officer effective December 31, 2024.
On September 3, 2024, the Company announced that, effective January 1, 2025, following Ms. Bryan’s retirement, James Morgado will be appointed as the Chief Financial Officer of the Company.
he will continue to serve as SITE Centers’ Executive Vice President, Chief Financial Officer and Treasurer until the Spin-Off Date (at which time he is expected to cease serving in such roles for SITE Centers)
Stephen LaMond, PharmD., MBA resigned from his positions as Interim Chief Executive Officer and Chief Operating Officer of Peak Bio, Inc. (the “Company”), effective August 31, 2024.
the Company’s Board of Directors (the “Board”) determined that Hoyoung Huh, M.D., PhD, Executive Chairman of the Board, in his capacity as such, would assume the responsibilities of the Company’s chief executive officer, effective August 31, 2024.
Also, effective August 30, 2024, the Board of Directors of the Company (the “Board”) appointed Andrew D. Jones to the positions of Chief Financial Officer, Treasurer and Secretary of the Company.
John Gandolfo retired from his positions as Chief Financial Officer, Treasurer and Secretary of Eyenovia, Inc. (the “Company”).
On August 29, 2024, the board of directors of Aldeyra Therapeutics, Inc. (the “Company”) approved the appointment of Michael Alfieri as the Company’s principal financial officer and principal accounting officer effective as of August 31, 2024 (the “Effective Date”).
the Company’s board of directors (the “Board”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which was anticipated to be September 1, 2024.
On August 30, 2024, Mr. Kenneth Galbraith resigned from the positions of interim Chief Financial Officer and as principal financial officer and principal accounting officer of the Company, effective as of the Start Date.
On August 28, 2024, Suzanne Winter, President and Chief Executive Officer of Accuray Incorporated (the “Company”) informed the board of directors of the Company (the “Board”) that she is taking a temporary medical leave of absence, effective September 3, 2024.
On August 30, 2024, in connection with Ms. Winter’s leave of absence and effective September 3, 2024, the Board appointed Sandeep Chalke, the Company’s Chief Commercial Officer, as the Company’s interim Chief Executive Officer and interim principal executive officer.
On August 27, 2024, Sonalee Parekh informed RingCentral, Inc. (the “Company”) of her intention to resign as the Company’s Chief Financial Officer and as the Company’s principal financial officer under Section 16a-1(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), effective September 10, 2024, to accept a Chief Financial Officer role at a public company that is not a competitor, supplier, or customer of RingCentral.
the Board appointed Ms. Sonalee Parekh as Chief Financial Officer and Head of Finance of the Company, effective as of September 11, 2024
Tim Wan tendered to the Board of Directors (the “Board”) of Asana, Inc. (the “Company”) his resignation as Chief Financial Officer of the Company, effective as of September 10, 2024.
Mr. Jolley will continue as an employee of the Company, serving as senior adviser, finance, effective November 1, 2024.
appointed Tod Crane as the Company's chief financial officer, effective November 1, 2024.
On September 1, 2024, Jason O’Byrne, the Chief Financial Officer of Caribou Biosciences, Inc. (the “Company”), informed the Company of his intent to resign from his position, effective September 27, 2024, to pursue another opportunity.
On September 3, 2024, the Company announced the appointment of Ashley Cordova, age 45, who is currently serving as the Company’s Chief Financial Officer, as the Chief Executive Officer of the Company and its respective direct and indirect subsidiaries and affiliates (together, the “Novocure Group”), effective January 1, 2025.
On August 29, 2024, C. Timothy Trenary, 68, Executive Vice President, Chief Financial Officer of Superior Industries International, Inc. (the “Company” or “Superior”), notified the Company of his intent to retire from his position at Superior effective September 30, 2024.
Dan Lee, Superior’s Vice President of Finance and CFO Europe, has been appointed to serve as the Company’s Senior Vice President, Chief Financial Officer beginning on October 1, 2024.
Mark Austin ceased serving as an executive officer of the Company and as the Company's “co-principal financial officer” and “principal accounting officer” on August 16, 2024.
On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the “Company”), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity.
appointed Roy M. Gonzales, the Company’s Senior Vice President of Finance, as the Company’s interim principal financial officer and interim principal accounting officer, effective as of August 30, 2024
Dr. Auster ceased employment as the Company’s Chief Financial Officer, effective as of August 30, 2024.
Joseph A. Mills, a member of the Company’s Board of Directors (the “Board”), will serve as Interim Chief Executive Officer and President, effective as of August 29, 2024.
Timothy S. Duncan departed his role as President and Chief Executive Officer of the Company, effective as of August 29, 2024.
In addition, Amit Kumar Garg resigned as Chief Financial Officer of the Company as of the Effective Date.
Blink Charging Co. (the “Company”) is reporting that Brendan Jones, the Company’s President and Chief Executive Officer, informed the Board of Directors of the Company (the “Board”) on August 27, 2024, that he will step down from his role as the Company’s President and Chief Executive Officer and will retire from the Company effective January 31, 2025.
The Company is also reporting that the Board has appointed Michael Battaglia to serve as the successor to Mr. Jones as the Company’s President and Chief Executive Officer effective February 1, 2025.
Effective August 30, 2024, the board of directors (the “Board”) of OneMedNet Corporation (the “Company”) appointed Robert Golden to serve as Chief Financial Officer (“CFO”) on an interim basis.
Effective August 30, 2024, Lisa Embree departed as the Company’s CFO, Executive Vice President, Treasurer and Secretary.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.